References
Reference
Falagas ME, Alexiou VG. An analysis of trends in globalisation of origin of research published in major general medical journals. Int J Clin Pract 2008 Jan; 62 (1): 71–5
Reference
Hackam DG, Hackam AS. Translation of genetic discoveries into clinical therapies. Ann Intern Med 2008 Feb 3; 148 (3): 246–7
Reference
Klein DF. The loss of serendipity in psychopharmacology. JAMA 2008 Mar 5; 299 (9): 1063–5
Reference
Jack A. Balancing big pharma’s books. BMJ 2008 Feb 23; 336 (7641): 418–9
Reference
Kip KE, Hollabaugh K, Marroquin OC, et al. The problem with composite end points in cardiovascular studies: the story of major adverse cardiac events and percutaneous coronary intervention. J Am Coll Cardiol 2008 Feb 19; 51 (7): 701–7
Reference
O’Neil P. Ethics guidelines for clinical trials to be revised. CMAJ 2008 Jan 15; 178 (2): 138
Reference
Groves T. Mandatory disclosure of trial results for drugs and devices: new US law will require public posting of all the main results and data on harms. BMJ 2008 Jan 26; 336 (7637): 170
Reference
MHRA. Members of the public to be encouraged by pharmacists to report suspected side effects of medicines. Media Release: 18 Feb 2008 [online]. Available from URL: http://www.mhra.gov.uk
Rights and permissions
About this article
Cite this article
Forum. Pharm Med 22, 127–129 (2008). https://doi.org/10.1007/BF03256692
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03256692